$3.04 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Neximmune

NexImmune, Inc. operates as a biopharmaceutical company. The Company develops immuno-therapies for the treatment of cancer, inflammation, viral diseases, transplant rejection, autoimmunity, and other related diseases. NexImmune serves patients in the United States.

Stock Analysis

last close $3.35
1-mo return -31.5%
3-mo return -73.3%
avg daily vol. 54.54T
52-week high 28
52-week low 3.17
market cap. $84M
forward pe -
annual div. -
roe -253.3%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 47%

Subscribe now for daily local and international financial news